Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Columbia University
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco